.

Browsing Gilbert and Rose-Marie Chagoury School of Medicine by Author "Wolff, Robert"

LAUR Repository

Browsing Gilbert and Rose-Marie Chagoury School of Medicine by Author "Wolff, Robert"

Sort by: Order: Results:

  • Overman, Micheal; Fogelman, David; Al-Kali, Aref; Crane, Christopher; Evans, Douglas; Abdalla, Eddie; Pisters, Peter; Kopetz, Scott; Eng, Cathy; Wolff, Robert (2015-11-17)
    We report 5 cases in which the recurrence of colorectal cancer (CRC) presented as a mass involving the duodenum and pancreas. The treatment approach for such recurrences is not standardized, and in particular, the benefits ...
  • Tzeng, Ching-Wei; Fleming, Jason; Lee, Jeffrey; Xiao, Lianchun; Pisters, Peter; Vauthey, Jean-Nicolas; Abdalla, Eddie; Wolff, Robert; Varadhachary, Gauri; Fogelman, David; Crane, Christopher; Balachandran, Aparna; Katz, Matthew (2015-11-20)
    Background We previously introduced a classification system for patients with localized pancreatic adenocarcinoma that integrates assessments of tumor anatomy, cancer biology, and patient physiology. By means of this ...
  • Abdalla, Eddie; Aloia, Thomas; Lee, Jeffrey; Vauthey, Nicolas; Wolff, Robert; Varadhachary, Gauri; Abbruzzese, James; Crane, Christopher; Evans, Douglas; Pisters, Peter (2015-11-12)
    Background Delayed recovery after pancreaticoduodenectomy (PD) is believed to preclude adjuvant therapy for approximately 30% of patients who undergo elective PD as initial treatment for pancreatic adenocarcinoma. This ...
  • Curley, Steven; Marra, Paolo; Beaty, Karen; Vauthey, Nicolas; Abdalla, Eddie; Scaife, Courtney; Raut, Chan; Wolff, Robert; Choi, Haesun; Loyer, Evelyne; Vallone, Paolo; Fiore, Francesco; Scordino, Fabrizio; Di Rosa, Vincenzo; Orlando, Raffaele; Pignata, Sandro; Daniele, Bruno; Izzo, Francesco (2015-11-10)
    Background: Radiofrequency ablation (RFA) has become a common treatment of patients with unresectable primary and secondary hepatic malignancies. We performed this prospective analysis to determine early (within 30 days) ...
  • Katz, Matthew; Wang, Huamin; Balachandran, Aparna; Bhosale, Priya; Crane, Christopher; Wang, Xuemei; Pisters, Peter; Lee, Jeffrey; Vauthey, Jean-Nicolas; Abdalla, Eddie; Wolff, Robert; Abbruzzese, James; Varadhachary, Gauri; Chopin-Laly, Xavier; Chamsangavej, Chulsip; Fleming, Jason (2015-11-20)
    Objectives To determine the influence of neoadjuvant chemoradiation and standardized dissection of the superior mesenteric artery upon the oncologic outcome of patients with localized pancreatic adenocarcinoma. Methods One ...
  • Raut, Chandrajit; Tseng, Jennifer; Sun, Charlotte; Wang, Huamin; Wolff, Robert; Crane, Christopher; Vauthey, Nicolas; Abdalla, Eddie; Lee, Jeffrey; Pisters, Peter; Evans, Douglas (2015-11-16)
    Objective: To better understand the impact of a microscopically positive margin (R1) on patterns of disease recurrence and survival after pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma. Summary Background ...
  • Katz, Matthew; Wang, Huamin; Fleming, Jason; Sun, Charlotte; Hwang, Rosa; Wolff, Robert; Varadhachary, Gauri; Abbruzzese, James; Crane, Christopher; Krishnan, Sunil; Vauthey, Jean-Nicolas; Abdalla, Eddie; Lee, Jeffrey; Pisters, Peter; Evans, Douglas (2015-11-17)
    Introduction Actual 5-year survival rates of 10–18% have been reported for patients with resected pancreatic adenocarcinoma (PC), but the use of multimodality therapy was uncommon in these series. We evaluated long-term ...
  • Abdalla, Eddie; Tseng, Jennifer; Raut, Chandrajit; Lee, Jeffrey; Pisters, Peter; Vauthey, Nicolas; Gomez, Henry; Sun, Charlotte; Crane, Christopher; Wolff, Robert; Evans, Douglas (2015-11-11)
    Major vascular resection performed at the time of pancreaticoduodenectomy (PD) for adenocarcinoma remains controversial. We analyzed all patients who underwent vascular resection (VR) at the time of PD for any histology ...
  • Blazer III, Dan; Kishi, Yoji; Maru, Dipen; Shin Chun, Yun; Overman, Micheal; Fogelman, David; Eng, Cathy; Chang, David; Wang, Huamin; Zorzi, Daria; Ribero, Dario; Ellis, Lee; Glover, Katrina; Wolff, Robert; Curley, Steven; Abdalla, Eddie; Vauthey, Nicolas (2015-11-16)
    Purpose The primary goal of this study was to evaluate whether pathologic response to chemotherapy predicts patient survival after preoperative chemotherapy and resection of colorectal liver metastases (CLM). The secondary ...
  • Estrella, Jeannelyn; Rashid, Asif; Fleming, Jason; Katz, Matthew; Lee, Jeffrey; Wolff, Robert; Varadhachary, Gauri; Pisters, Peter; Abdalla, Eddie; Vauthey, Jean-Nicolas; Wang, Hua; Gomez, Henry; Evans, Douglas; Abbruzzese, James; Wang, Huamin (2015-11-20)
    BACKGROUND: Neoadjuvant chemoradiation before surgery is an emerging treatment modality for pancreatic ductal adenocarcinoma (PDAC). However, analysis of prognostic factors is limited for patients with PDAC treated with ...
  • Varadhachary, Gauri; Wolff, Robert; Crane, Christopher; Sun, Charlotte; Lee, Jeffrey; Pisters, Peter; Vauthey, Jean-Nicolas; Abdalla, Eddie; Wang, Huamin; Staerkel, Gregg; Ross, William; Tamm, Eric; Bhosale, Priya; Krishnan, Sunil; Das, Prajnan; Ho, Linus; Xiong, Henry; Abbruzzese, James; Evans, Douglas (2015-11-17)
    Purpose We conducted a phase II trial of preoperative gemcitabine and cisplatin chemotherapy in addition to chemoradiation (Gem-Cis-XRT) and pancreaticoduodenectomy (PD) for patients with stage I/II pancreatic adenocarci ...
  • Katz, Matthew; Varadhachary, Gauri; Fleming, Jason; Wolff, Robert; Lee, Jeffrey; Pisters, Peter; Vauthey, Jean-Nicolas; Abdalla, Eddie; Sun, Charlotte; Wang, Huamin; Crane, Christopher; Lee, Jeffrey; Tamm, Eric; Abbruzzese, James; Evans, Douglas (2015-11-19)
    Purpose The role of carbohydrate antigen (CA) 19-9 in the evaluation of patients with resectable pancreatic cancer treated with neoadjuvant therapy prior to planned surgical resection is unknown. We evaluated CA 19-9 as ...

Search LAUR


Advanced Search

Browse

My Account